Mellon gives development update at Charing Cross International Symposium 2018
At the Charing Cross Vascular Symposium, April 26th, Dr. Mark Vrancken Peeters provided the vascular community an update on the development of the Switch® suturing device.
Many good thinks have happened since Mellon Medical won the Dragon’s Den Innovation Award at the CX 2016 Event. Finalization of the financing round and a new subsidy from the Dutch Government, puts Mellon in the position to complete the design and attain CE-mark after preclinical and clinical testing.
The suturing innovation from Mellon will have a first market introduction in The Netherlands and Germany. Surgeons were enthusiastic to hear the development progress and are awaiting the availability of the Switch® in the near future.